EconPapers    
Economics at your fingertips  
 

The demand for a COVID-19 vaccine

Sizhong Sun

Economics & Human Biology, 2022, vol. 46, issue C

Abstract: Taking willingness to pay as primitive, this paper establishes an analytical framework for demand estimation, where the estimator is robust to endogeneity of price. Applying the framework, this paper then estimates demand functions for a COVID-19 vaccine and compute the consumer surplus in both China and the UAE. We find that the price elasticities of demand are mostly greater than one in both countries. An elastic demand suggests subsidy is likely to be successful in promoting vaccination. The consumer surplus is sizeable, around 58 billion US$ in China and 646 million US$ in the UAE. The figures can inform policymakers in assessing their vaccine programs.

Keywords: Demand for vaccine; Demand estimation; Willingness to pay; COVID-19; Contingent valuation; China; UAE (search for similar items in EconPapers)
JEL-codes: D12 I12 (search for similar items in EconPapers)
Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S1570677X22000314
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:ehbiol:v:46:y:2022:i:c:s1570677x22000314

DOI: 10.1016/j.ehb.2022.101135

Access Statistics for this article

Economics & Human Biology is currently edited by J. Komlos, Inas R Kelly and Joerg Baten

More articles in Economics & Human Biology from Elsevier
Bibliographic data for series maintained by Catherine Liu ().

 
Page updated 2022-11-12
Handle: RePEc:eee:ehbiol:v:46:y:2022:i:c:s1570677x22000314